Exfoliative dermatitis - Dermatitis Ea Exfoliative
☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
Red (burning) Skin Syndrome ― Erythema le sekala 'meleng kaofela ke matšoao a mantlha a Dermatitis Ea Exfoliative (Exfoliative dermatitis).
References
Erythroderma ke boemo ba letlalo bo sa tloaelehang empa bo tebile. Le hoja hangata sesosa se tobileng se sa tsejoe, se ka bakoa ke karabelo ea lithethefatsi kapa kankere e ka sehloohong. Kankere e 'ngoe e tloaelehileng e amanang le dermatitis ea exfoliative ke T-cell lymphoma ea cutaneous, e ka 'nang ea se ke ea bontša matšoao ka likhoeli kapa lilemo ka mor'a hore letlalo le qale. Hangata, ho hlokahala ho kena sepetlele bakeng sa tlhahlobo ea pele le kalafo. Bakuli ba nang le lefu le bakoang ke lithethefatsi ka kakaretso ba na le pono e ntle ea nako e telele, le hoja linyeoe tse se nang lebaka le hlakileng li atisa ho ba le mokhoa o iphetang le oa ho khutlisa. Polelo ea linyeoe tse amanang le mofetše hangata e ipapisitse le hore na mofets'e o tsoela pele joang.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
E bonts'a bofubelu bo atileng le ho ruruha ho koahelang karolo ea 90% ea 'mele. Boemo bona ke sesupo se bonahalang sa mathata a fapaneng a bophelo bo botle joalo ka psoriasis, eczema, kapa karabelo ea meriana e itseng.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Sesosa se atileng haholo sa erythroderma ke ho mpefala ha lefu la letlalo le ka tlase, joalo ka psoriasis, ho kopana le dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris kapa karabelo ea lithethefatsi, joalo ka tšebeliso ea li-topical steroids. Ts'ebetso ea mantlha ha e tloaelehe, 'me hangata e bonoa maemong a T-cell lymphoma ea cutaneous. Hobane ho bohlokoa ho e khetholla ho T cell lymphoma ea cutaneous, biopsy e etsoa.